Anavex Reports Fiscal First Quarter 2017 Financial Results

Anavex Reports Fiscal First Quarter 2017 Financial Results

NEW YORK – February 7, 2017 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...
Anavex Life Sciences Reports Fiscal 2016 Financial Results

Anavex Life Sciences Reports Fiscal 2016 Financial Results

Conference Call and Webcast Today at 4:30 p.m. ET to Discuss Financial Results and Clinical Progress NEW YORK – December 12, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company...